The Role of Hepcidin, sTfR, and sTfR/Log Ferritin Index for the Differential Diagnosis of Iron Deficiency Anemia and Anemia of Chronic Disease

ORIGINAL ARTICLE
Alma Barbullushi (Rucaj), Anila Kristo, Anila Lika, Donjeta Bali, Ervin Toçi, Anila Godo

 
For citation: Barbullushi (Rucaj) A, Kristo A, Lika A, Bali D, Toçi E, Godo A. The Role of Hepcidin, sTfR, and sTfR/Log Ferr Index for The Differential Diagnosis of Iron Deficiency Anemia and Anemia of Chronic Disease. International Journal of Biomedicine. 2024;14(1):45-51. doi:10.21103/Article14(1)_OA6
 
Originally published March 1, 2024

Abstract: 

Background: In chronic diseases characterized by persistent inflammation, anemia of chronic disease (ACD) and iron deficiency anemia (IDA) are commonly encountered forms of anemia and can often co-occur. In such situations, the conventional iron status tests used for differential diagnosis are influenced by inflammation, reducing their diagnostic accuracy. The primary objective of this study was to assess the significance of hepcidin as a crucial diagnostic marker for ACD and to investigate the correlation between hepcidin and inflammation-related indicators. Furthermore, a significant secondary aim of this research was to ascertain the diagnostic role of novel biochemical markers, specifically soluble transferrin receptor (sTfR) and the derived sTfR/log ferritin index (sTfR-F index).
Methods and Results: This study was conducted at the Laboratory Service of the University Hospital Center "Mother Teresa" and included a cohort of 187 subjects, comprising 156 patients (83 females and 73 males) who were admitted to and received treatment at the Rheumatology and Cardiology Departments of the "Mother Teresa" University Hospital Center in Tirana. Additionally, 31 individuals without anemia and inflammatory conditions were included as a control group. All subjects incorporated into the study were classified into five distinct groups based on a comprehensive analysis of their complete blood profiles, iron status, and inflammation-related biomarkers: IDA, ACD, ACD+IDA, RA/CHF patients without anemia, and the control group without anemia.
The comparison between groups showed that the mean values of pro-hepcidin, TNFα, IL6, Hs-PCR, and ferritin are significantly decreased in IDA vs. ACD, while sTFR and sTfR-F index are significantly increased. In comparing ACD vs. ACD+IDA groups, ferritin increased significantly in the ACD group, while sTFR and sTfR-F index decreased significantly in ACD, compared to the ACD+IDA group. The ROC curves analysis of the biochemical parameters selected for the comparison of ACD vs IDA showed that the pro-hepcidin test is a perfect test for the differential diagnosis of ACD vs. IDA. The suggested cut-off value for pro-hepcidin was ≥153 ng/ml, yielding a sensitivity of 100% and a specificity of 100% for the diagnosis of ACD. As regards sTFR, the suggested cut-off value for the diagnosis of IDA vs. ACD was  ≥ 4.9 µg/ml resulting in 84% sensitivity and 100% specificity. The sTfR-F index was also very useful for the diagnosis of IDA vs. ACD: for a cut-off value of ≥2.06, the sensitivity was 90% and the specificity was 96%. sTfR resulted in a good test for the diagnosis of ACD+IDA vs. ACD: the cut-off value was ≥ 3.7µ/ml, the sensitivity was 92.3% and the specificity was 93.2%. Similarly, the parameter sTfR-F index resulted in a very good test for the diagnosis of ACD+IDA vs. ACD: for the suggested cut-off value of ≥2.3, the sensitivity was 92.3% and the specificity was 100%.
Conclusion: As a result of the study, it was found that the pro-hepcidin test was a highly accurate test for distinguishing between ACD and IDA. Meanwhile, sTfR and the sTfR-F index proved to be excellent indicators for the differential diagnosis of IDA in chronic inflammatory conditions.

Keywords: 
anemia of chronic disease • iron deficiency anemia• pro-hepcidin • transferrin receptor
References: 
  1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005 Mar 10;352(10):1011-23. doi: 10.1056/NEJMra041809. PMID: 15758012.
  2. Means RT Jr. Recent developments in the anemia of chronic disease. Curr Hematol Rep. 2003 Mar;2(2):116-21. PMID: 12901142.
  3. Peeters HR, Jongen-Lavrencic M, Raja AN, Ramdin HS, Vreugdenhil G, Breedveld FC, Swaak AJ. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis. 1996 Mar;55(3):162-8. doi: 10.1136/ard.55.3.162. PMID: 8712878; PMCID: PMC1010122.
  4. Baer AN, Dessypris EN, Krantz SB. The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum. 1990 Feb;19(4):209-23. doi: 10.1016/0049-0172(90)90001-v. PMID: 2181669.
  5. Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). Semin Hematol. 1988 Jul;25(3):208-18. PMID: 3043675.
  6. Siciliano M, Tomasello D, Milani A, Ricerca BM, Storti S, Rossi L. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia. Hepatology. 1995 Oct;22(4 Pt 1):1132-5. doi: 10.1016/0270-9139(95)90620-7. PMID: 7557862.
  7. Okonko DO, Van Veldhuisen DJ, Poole-Wilson PA, Anker SD. Anaemia of chronic disease in chronic heart failure: the emerging evidence. Eur Heart J. 2005 Nov;26(21):2213-4. doi: 10.1093/eurheartj/ehi509. Epub 2005 Oct 4. PMID: 16204265.
  8. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999 Oct 6;91(19):1616-34. doi: 10.1093/jnci/91.19.1616. Erratum in: J Natl Cancer Inst 2000 Mar 15;92(6):497. PMID: 10511589.
  9. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17. PMID: 19293425.
  10. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003 Aug 1;102(3):783-8. doi: 10.1182/blood-2003-03-0672. Epub 2003 Mar 27. PMID: 12663437.
  11. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004 May;113(9):1271-6. doi: 10.1172/JCI20945. PMID: 15124018; PMCID: PMC398432.
  12. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G199-203. doi: 10.1152/ajpgi.00412.2005. PMID: 16407589.
  13. Alvarez-Hernández X, Licéaga J, McKay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest. 1989 Sep;61(3):319-22. PMID: 2788773.
  14. Cartwright GE. The anemia of chronic disorders. Semin Hematol. 1966 Oct;3(4):351-75. PMID: 5341723.
  15. Theurl I, Mattle V, Seifert M, Mariani M, Marth C, Weiss G. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood. 2006 May 15;107(10):4142-8. doi: 10.1182/blood-2005-08-3364. Epub 2006 Jan 24. PMID: 16434484.
  16. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003 Oct;49(10):1573-8. doi: 10.1373/49.10.1573. PMID: 14500582.
  17. Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, Chamberlin JS, Sullivan LA, Bray KR, Southwick PC. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011 Nov;86(11):923-7. doi: 10.1002/ajh.22108. Epub 2011 Aug 2. PMID: 21812017.
  18. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998 Jan;44(1):45-51. PMID: 9550557.
  19. Günther F, Straub RH, Hartung W, Fleck M, Ehrenstein B, Schminke L. Usefulness of Soluble Transferrin Receptor in the Diagnosis of Iron Deficiency Anemia in Rheumatoid Arthritis Patients in Clinical Practice. Int J Rheumatol. 2022 Oct 12;2022:7067262. doi: 10.1155/2022/7067262. PMID: 36275413; PMCID: PMC9581666.
  20. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 2002 Jun;16(2):87-96. doi: 10.1054/blre.2002.0193. PMID: 12127952.
  21. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992 Mar-Apr;7(2):145-53. doi: 10.1007/BF02598003. Erratum in: J Gen Intern Med 1992 Jul-Aug;7(4):423. PMID: 1487761.
  22. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009 May 21;113(21):5277-86. doi: 10.1182/blood-2008-12-195651. Epub 2009 Mar 17. PMID: 19293425.
  23. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997 Feb 1;89(3):1052-7. PMID: 9028338.
  24. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998 Jan;44(1):45-51. PMID: 9550557.
  25. Juncà J, Fernández-Avilés F, Oriol A, Navarro JT, Millá F, Sancho JM, Feliu E. The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders. Haematologica. 1998 Aug;83(8):676-80. PMID: 9793248.
  26. Bianco I, Mastropietro F, D'Asero C, Graziani B, Piergrossi P, Mezzabotta M, Modiano G. Serum levels of erythropoietin and soluble transferrin receptor in the course of pregnancy in non beta thalassemic and beta thalassemic women. Haematologica. 2000 Sep;85(9):902-7. PMID: 10980626.
  27. Ferguson BJ, Skikne BS, Simpson KM, Baynes RD, Cook JD. Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia. J Lab Clin Med. 1992 Apr;119(4):385-90. PMID: 1583389.
  28. Suominen P, Punnonen K, Rajamäki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 1998 Oct 15;92(8):2934-9. PMID: 9763580.
  29. Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med. 2005 Apr 28;352(17):1741-4. doi: 10.1056/NEJMp048363. PMID: 15858181.
  30. Delaby C, Deybach JC, Beaumont C. L'hepcidine et le métabolisme du fer [Hepcidin and iron metabolism]. Rev Med Interne. 2007 Jul;28(7):510-2. [Article in French]. doi: 10.1016/j.revmed.2007.03.009. Epub 2007 Apr 5. PMID: 17445953.

Download Article
Received December 3, 2023.
Accepted January 13, 2024.
©2024 International Medical Research and Development Corporation.